NCT03735511Unknown不适用
A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 270
- 试验地点
- 1
- 主要终点
- Overall Survival
研究概览
简要总结
The study was designed to evaluate the efficacy and safety of apatinib in the treatment of patients with gastric carcinoma.
详细描述
The study is a real-world non-interventional retrospective study and will collect the original medical records of patients with gastric carcinoma treated with apatinib from 2015 to 2018 in Henan Cancer Hospital. Clinical data such as patient demographic, history of treatments, tumor biological characteristics and adverse events will be analyzed to evaluate the efficacy and safety of apatinib and explore the risk factors of prognosis in patients with gastric carcinoma.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pathologically or cytologically confirmed gastric or residual gastric or gastroesophageal junction carcinoma;
- •Patients received apatinib treatment at least once.
排除标准
- •No specific exclusion criteria in this real world study.
结局指标
主要结局
Overall Survival
时间窗: 2015-2018
Overall Survival
次要结局
- Progression-Free Survival(2015-2018)
- Objective Response Rate(2015-2018)
- Disease Control Rate(2015-2018)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast CancerBreast Cancer MetastaticNCT03086785Hebei Medical University Fourth Hospital120
Unknown
2 期
Apatinib for Advanced Non-squamous Head and Neck CancerHead and Neck NeoplasmsNCT02989259Cancer Institute and Hospital, Chinese Academy of Medical Sciences30
Unknown
2 期
A Study of Apatinib in Recurrent or Recurrent High-grade GliomaGliomaNCT03390062West China Hospital30
已完成
4 期
A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerAdvanced Gastric or Gastroesophageal Junction AdenocarcinomaNCT02426034Jiangsu HengRui Medicine Co., Ltd.2,004
招募中
2 期
Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric CancerApatinibBiomarkerGastric CancerNCT03219593The First Affiliated Hospital of Bengbu Medical University30